Literature DB >> 8083461

Rush Hymenoptera venom immunotherapy: successful treatment in a patient with systemic mast cell disease.

R J Engler1, W S Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8083461     DOI： 10.1016/0091-6749(94)90213-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  4 in total

Review 1.  Anaphylaxis as a clinical manifestation of clonal mast cell disorders.

Authors:  A Matito; I Alvarez-Twose; J M Morgado; L Sánchez-Muñoz; A Orfao; L Escribano
Journal:  Curr Allergy Asthma Rep       Date:  2014-08       Impact factor: 4.806

Review 2.  Hymenoptera Allergy and Mast Cell Activation Syndromes.

Authors:  Patrizia Bonadonna; Massimiliano Bonifacio; Carla Lombardo; Roberta Zanotti
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806

Review 3.  Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.

Authors:  David González-de-Olano; Almudena Matito; Alberto Orfao; Luis Escribano
Journal:  F1000Res       Date:  2016-11-14

4.  Twelve-hour ultrarush immunotherapy in a patient with mastocytosis and hymenoptera sting anaphylaxis.

Authors:  Doris Jäger; Jürgen Barth
Journal:  World Allergy Organ J       Date:  2009-03       Impact factor: 4.084
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.